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Patients and methods: We retrospectively analyzed the clinical data of children with vitiligo pre-
sented to the dermatology outpatient clinic at King Abdul Aziz Medical City – Jeddah from
May 2009 to May 2010. This study included 38 patients. All patients were assessed for the natural
history, clinical characteristics, family history, and associated abnormalities of vitiligo.
Results: Of the 38 children with vitiligo 14 (36.9%) were boys and 24 (63.2%) were girls. The mean
age of onset of the vitiligo was 7.9 years. The mean duration of the disease was 49.7 weeks. The
most common type of vitiligo was vitiligo vulgaris (60.5%) followed by acrofacial vitiligo
(26.5%), focal vitiligo (23.7%), and segmental vitiligo (2.6%). The most frequent site of onset
was the head and the neck, followed by the extremities, the trunk and the genitalia. Of the 38
children with vitiligo, 14 (36.9%) had a family history and 4 (10.5%) had a positive anti-thyroid
antibodies.
Conclusion: Our children have a strong family history of vitiligo and they are developing the
disease at a slightly older age compared with those of other studies; however, other epidemiologic
features appear to be similar to those reported in the previously published studies.
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lsevier1. Introduction
Vitiligo is an acquired, sometimes familial depigmentary disor-
der of the skin and hair which results from selective destruction
of melanocytes. The prevalence of vitiligo ranges from 0.1% to
2% in various populations (Lerner and Nordlund, 1978;
Howitz et al., 1977; Bolognia and Pawelek, 1988). Approxi-
mately half of the patients reported in the literature ﬁrst were
observed with the onset of vitiligo before the age of 18 years
and a quarter before the age of 8 years (Jaisankar et al.,
1992; Halder et al., 1987; Koga and Tango, 1988; Nordlund
and Lerner, 1982; McBurney, 1979; Barnes and Nordlund,
Table 3 Associated diseases/abnormalities.
Associated diseases/abnormalities No. of cases
Alopecia areata 1
Antithyroid antibodies 4
Atopic dermatitis 2
16 M.M. Al-Jabri, A. Al-Raddadi1987). Vitiligo in childhood can be associated with signiﬁcant
psychological trauma that may have long-lasting effects on
the self-esteem of these children. To the best of our knowledge,
no review has been published on the subject of childhood vit-
iligo in Saudi Arabia.
2. Patients and methods
A retrospective analysis was made on records of the patients
attending the dermatology clinic at King Abdul Aziz Medical
City – Jeddah during 1 year (May 2009–May 2010). All pa-
tients 613 years of age with vitiligo referred to the clinic were
included in this study.
The diagnosis was made by experienced dermatologists and
was essentially clinical.
Demographic details of all patients including the age of on-
set, initial site of onset, duration of disease, associated mucosal
involvement, associated diseases, and family history were ob-
tained from the clinic notes.
3. Results
Of the total 38 children with vitiligo in the present study 14
(36.9%) were boys and 24 (63.2%) were girls. The age of onset
of vitiligo ranged from 3 to 13 years (mean 7.9 years). The
mean duration of disease was 49.7 weeks. Vitiligo affecting
ﬁrst and second-degree relatives was reported by 12 (35.3%)
patients including 8 girls (21.1%) and 4 boys (10.5%). The
most common clinical type of vitiligo seen in our patients is
vitiligo vulgaris (44.7%), followed by acrofacial (26.3%), focal
(26.3%), and segmental (2.6%), in that order (Table 1). The
most common site of onset was the head and the neck area
(50%), followed by the extremities (28.9%), the trunk
(15.8%) and the genitalia (5.3%) (Table 2). Nine children
had associated abnormalities. Four patients (10.5%) had posi-
tive anti-thyroid antibodies but no one showed a clinical evi-
dence of thyroid disease. One patient (2.6%) had alopecia
areata. Two patients (5.3%) had atopic eczema (Table 3).Table 1 Clinical types of vitiligo.
Clinical types Girls Boys Total (%)
Vulgaris 11 6 17 (44.7%)
Acrofacial 6 4 10 (26.3%)
Focal 5 5 10 (26.3%)
Segmental – 1 1 (2.6%)
Total 14 24 38 (100%)
Table 2 Distribution of vitiligo at onset.
Site of onset No. of cases
Head and neck 19
Trunk 6
Extremities 11
Genitalia (extramucosal) 2
Total 384. Discussion
There have been few studies focusing on vitiligo in children,
that is, those aged 13 or younger, although many studies state
that most vitiligo is primarily acquired early in life (Halder
et al., 1987). We have attempted to compare our ﬁndings with
those in the previous studies from different countries, a com-
parison of the patterns of vitiligo and its associated disorders
in different studies, including ours, is represented in Table 4.
The mean age of onset in the pediatric age group has been
found to be 4.6 years in an American study (Halder et al.,
1987), 5.6 years in a Korean study (Cho et al., 2000), and
6.2 years in Kuwaiti study (Al-Mutairi et al., 2005). Our results
reveal that the mean age of onset was 7.9 years, which mean
that our patients develop vitiligo in a slightly older age than
in others. The exact reasons for this are unclear. Our review
show a preponderance of girls in children with vitiligo, similar
to the observation made in majority of previously reported
studies (Jaisankar et al., 1992; Halder et al., 1987; Al-Mutairi
et al., 2005). Although, two studies from Korea and China
noted an almost equal incidence in boys and girls (Cho
et al., 2000; Hu et al., 2006), we think that the reason behind
this is that the girls are brought to hospital at an earlier age
compared with boys.
Approximately 37% of patients in our study had a family
history of vitiligo comparable to both American and Kuwaiti
studies (Table 4). We believe that genetic factors play a role
herein, as there is a high incidence of consanguineous marriage
in our country.
In earlier published reports on childhood vitiligo, vitiligo
vulgaris was the most frequent type reported (Jaisankar
et al., 1992; Halder et al., 1987). In our study as well, this is
the most common clinical type seen in 44.7%.
Similar to our ﬁnding Halder et al. (1987), focal vitiligo
was the second most common presentation. However,
Jaisankar et al. (1992), in their study with 90 children, they
reported segmental vitiligo as the second most frequent presen-
tation, occurring in 21% of patients, closely followed by focal
vitiligo in 20.1%. The percentage of segmental vitiligo has
been reported to vary from 19% to 21% in children (Jaisankar
et al., 1992; Halder et al., 1987). Segmental vitiligo was seen in
only 2.6% of our patients. These differences could be due to
racial or even genetic factors.
In our report we did not encountered any patient with uni-
versal vitiligo. This type of vitiligo was the least type reported
in Kuwait, China, and North India 1.1%, 0.4%, and 0.3%,
respectively (Al-Mutairi et al., 2005; Hu et al., 2006; Handa
and Dogra, 2003).
The head and the neck were the most common sites of onset
in children in our series (50%), which are consistent with the
observations of other studies (Jaisankar et al., 1992; Cho
et al., 2000; Al-Mutairi et al., 2005; Handa and Dogra,
2003). The association of vitiligo with other diseases/abnor-
malities has also been a subject of great interest. A previous
Table 4 Comparison of patterns of vitiligo and observed associated disorders between different studies, including our study.
Country of study Period of
study (years)
Female
patients (%)
Mean age of onset
(years)
Positive family
history of vitiligo (%)
Associated disorders/abnormalities
USA Not stated 57.5 4.6 35.0 Serum autoantibodies
Ocular involvement
North India 1 61.1 Not stated 3.3 Septic foci in teeth
Intestinal parasitosis
South India Not stated 51.3 5.6 13.8 Alopecia areata
Korea 10 57.1 Not stated 12.2 Alopecia areata
Kuwait 1 56.3 6.2 27.3 Addison’s disease
Alopecia areata
Diabetes mellitus
Pemphigus vulgaris
Polyglandular syndrome
Thyroid disease
Our study 1 63.2 7.9 36.9 Alopecia areata
Antithyroid antibodies
Atopic dermatitis
Childhood vitiligo: A retrospective hospital based study, Jeddah, Saudi Arabia 17study reported that four children of 33 (12.1%) screened had
antithyroid antibodies, although they were all clinically asymp-
tomatic (Halder et al., 1987). This is consistent with our ﬁnd-
ing of antithyroid antibodies in 10.5% all of them were
clinically asymptomatic.
In our study 1 of 38 children (2.6%) had associated autoim-
mune disease namely, alopecia areata. This is consistent with
Halder et al. (1987) study as they reported two cases of alope-
cia areata in 82 children (2.4%) with vitiligo. One study from
Kuwait found 1.1% of children with vitiligo had alopecia are-
ata (Al-Mutairi et al., 2005).
In a study from North India, 1.3% of children (8 of 625
children) had an associated autoimmune disease including alo-
pecia areata, diabetes mellitus, thyroid disease, Addison’s dis-
ease, polyglandular syndrome or pemphigus vulgaris (Handa
and Dogra, 2003).
In addition, two studies have reported an increased preva-
lence of various autoantibodies in patients with vitiligo
(Betterle et al., 1985; Naughton et al., 1986). A recent article
has reported the presence of thyromegaly, antithyroid antibod-
ies and thyroid dysfunction in signiﬁcant numbers of children
and adolescents with vitiligo (Kurtev and Dourmishev, 2004).
5. Conclusion
We observe that children in our study have a strong family his-
tory of vitiligo than other population and are developing the
disease at a slightly older age compared with other studies;
however, other epidemiologic features appear to be similar to
those reported in the previously published studies.
References
Al-Mutairi, N., Sharma, A.K., Al-Sheltawy, M., Nour-Eldin, O., 2005.
Childhood vitiligo: a prospective hospital-based study. Australas. J.
Dermatol. 46 (3), 150–153.Barnes, L., Nordlund, J.J., 1987. Vitiligo. In: Demis, D.J. (Ed.),
Clinical Dermatology. JB Lippincott, Philadelphia, pp. 1–14.
Betterle, C., Caretto, A., De Zio, A., Pedini, B., Veller-Fornasa, C.,
Cecchetto, A., Accordi, F., Peserico, A., 1985. Incidence and
signiﬁcance of organ-speciﬁc autoimmune disorders (clinical,
latent, or only autoantibodies) in patients with vitiligo. Dermato-
logica 171, 419–423.
Bolognia, J.L., Pawelek, J.M., 1988. Biology of hypopigmentation. J.
Am. Acad. Dermatol. 19, 217–255.
Cho, S., Kang, H.C., Hahm, J.-H., 2000. Characteristics of vitiligo in
Korean children. Pediatr. Dermatol. 17, 189–193.
Halder, R.M., Grimes, P.E., Cowan, C.A., Enterline, J.A., Chakrab-
arti, S.G., Kenney Jr., J.A., 1987. Childhood vitiligo. J. Am. Acad.
Dermatol. 16, 948–954.
Handa, S., Dogra, S., 2003. Epidemiology of childhood vitiligo: a
study of 625 patients from north India. Pediatr. Dermatol. 20, 207–
210.
Howitz, J., Brodthagen, H., Schwartz, M., et al., 1977. Prevalence of
vitiligo. Epidemiological survey on the Isle of Bornholm Denmark.
Arch. Dermatol. 113, 47–52.
Hu, Z., Liu, J.B., Ma, S.S., Yang, S., Zhang, X.J., 2006. Proﬁle of
childhood vitiligo in China: an analysis of 541 patients. Pediatr.
Dermatol. 23 (2), 114–116.
Jaisankar, T.J., Baruah, M.C., Garg, B.R., 1992. Vitiligo in children.
Int. J. Dermatol. 31, 621–623.
Koga, M., Tango, T., 1988. Clinical features and course of type A and
type B vitiligo. Br. J. Dermatol. 118, 223–228.
Kurtev, A., Dourmishev, A.L., 2004. Thyroid function and autoim-
munity in children and adolescents with vitiligo. J. Eur. Acad.
Dermatol. Venerol. 18, 99–117.
Lerner, A.B., Nordlund, J.J., 1978. Vitiligo. What is it? Is it important?
JAMA 239, 1183–1187.
McBurney, E.I., 1979. Vitiligo: clinical picture and pathogenesis. Ann.
Intern. Med. 139, 1295–1297.
Naughton, G.K., Reggiado, D., Bystryn, J.C., 1986. Correlation
between vitiligo antibodies and extent of depigmentation in vitiligo.
J. Am. Acad. Dermatol. 15, 978–981.
Nordlund, J.J., Lerner, A.B., 1982. Vitiligo. Is it important? Arch.
Dermatol. 118, 5–8.
